Cladaxxa (2 - 4 kg)
Active substance
ATC code
Species
Cats and dogs.
Indications
For the treatment of infections caused by bacteria susceptible to amoxicillin and clavulanic acid including: skin disease (including deep and superficial pyodermas); soft tissue infections (abscesses and anal sacculitis); dental infections (e.g. gingivitis); urinary tract infections; respiratory disease (involving upper and lower respiratory tract); enteritis.
Dose to be administered and administration route
Administration: for oral use.
Dosage rate and frequency: 10 mg amoxicillin and 2.5 mg clavulanic acid/kg body weight (i.e. 12.5 mg of combined active substances per kg bodyweight), twice daily (corresponding to 25 mg of combined active substances per kg per day).
The following table is intended as a guide to dispensing the product at the recommended dose rate:
|
Bodyweight (kg) |
Number of tablets per dose twice daily |
|
1.0-2.0 |
½ |
|
2.1-4.0 |
1 |
|
4.1-6.0 |
1 ½ |
|
6.1-8.0 |
2 |
|
>8.0 |
Use 200 mg/50 mg or 400 mg/100 mg tablet(s) |
To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.
If the animal does not accept the tablet from hand or bowl, then the tablets may be crumbled and added to a little food and fed immediately.
Duration of therapy: The majority of routine cases respond to between 5 and 7 days therapy. In chronic cases, a longer course of therapy is recommended. In such circumstances, overall treatment length must be at the clinician’s discretion but should be long enough to ensure complete resolution of the bacterial disease.
Adverse reactions
Very rarely, hypersensitivity reactions to penicillins may occur in treated animals; in these cases, administration should be discontinued and a symptomatic treatment given.
Very rarely, gastro-intestinal disturbances (diarrhoea, vomiting, …) may occur after administration of the product. Treatment may be discontinued depending on the severity of the undesirable effects and a benefit/risk evaluation by the veterinary surgeon.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
References
Similar products
Showing 5 of 5 results
Cladaxxa (2 - 4 kg)
Cladaxxa (2 - 4 kg)
Cladaxxa (2 - 4 kg)
Cladaxxa (2 - 4 kg)
